3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course
|
|
|
- Imogen Heath
- 6 years ago
- Views:
Transcription
1 08/03/2017 Monday, june 19 th : Clinical management Chair: Roman Rouzier 10:15 Training Unit Welcome: practical aspects & coffee 10:30 11:15 11:15 11:45 Anne Vincent-Salomon & Roman Rouzier Mathilde His Anne Vincent-Salomon Welcome & introduction to the course Breast cancer epidemiology Breast cancer classification 11:45 12:05 Paper discussion Anne Tardivon Breast imaging: current concepts & controversies 14:40 14:40 15:00 Fabien Reyal Youlia Kirova Surgery: standards of care & perspectives Radiation therapy: standard of care and innovations 15:00 15:50 15:50 Etienne Brain Therapies in HR+ breast cancer 17:10 Véronique Diéras CLCC Eugène Marquis, Rennes - FR Suzette Delaloge Therapies in HER2+ breast cancer Therapies in triple negative breast cancer 17:10 17:30
2 08/03/2017 Tuesday, june 20 th : Genomics & Epigenomics Chair: Anne Vincent-Salomon 09:45 Jorge Reis-Filho Memorial Sloan Kettering Cancer Center, New York - USA Clinical impact of genomic classifications 09:45 10:05 10:05 10:50 Helen Davies Sanger Institute, Hinxton - UK Mutational signatures: tracking the origins of breast cancer 10:50 12:30 Alain Viari INRIA & Centre Léon Bérard, Lyon - FR Mechanisms of HER2 amplification 12:30 15:15 15:15 15:35 Claude Houdayer Charlotte Proudhon Current questions in germline diagnosis Circulating tumor cells & DNA 15:35 16:15 16:00 Raphaël Margueron Epigenetics in breast cancer 17:20 Philippe Chavrier Insights into in situ to invasive transition 17:20 17:40 17:40 18:30 POSTER SESSION #1 BDD Annexes
3 Wednesday, june 21 st : Microenvironment Chair: Fatima Mechta-Grigoriou Silvia Fre Mammary gland development Fatima Mechta-Grigoriou Breast cancer stroma 12:00 Olivier Herault CHU Tours, Tours - FR Stromal niche 12:00 13:30 Green Café 13:30 Laurence Zitvogel Fundamental basis of cancer immune therapy 15:10 Emanuela Romano Current status of immune therapy in breast cancer 15:10 François Ringeisen Laboratoires Lilly, Geneva - CH Research in Pharma POSTER SESSION #2 BDD Annexes
4 Thursday, june 22 nd : Resistance and metastases Chair: Jean-Yves Pierga Stéphan Vagner Institut Curie, Orsay - FR RNA biology and resistance to treatment in breast cancer Antonin Morillon Non coding genome & breast cancer 11:55 11:55 12:15 Muriel le Romancer Centre Léon Bérard, Lyon - FR Biology of estrogen receptor 12:15 13:45 13:45 Charlotte Ng University Hospital, Basel - CH Bioinformatics Paul Cottu Natural history and genomics of metastases 17:00 Carlos Caldas CRUK, Cambridge - UK Breast cancer heterogeneity 17:30 22:00 COCKTAIL & PARTY Chez Marie
5 Friday, june 23 rd : Experimental models Chairs: Stephan Vagner 10:00 Jos Jonkers NKI, Amsterdam - NL Mice preclinical models 11:05 11:05 11:50 Philippe Juin Université de Nantes, Nantes - FR Organoids and in vitro models 11:50 14:25 Christophe Ginestier Inserm U891, Marseille - FR Breast cancer stem cells 14:25 14:45 14:45 15:30 Roberto Buccione EMBO Molecular Medicine, Heidelberg - DE Publishing your paper 15:30 15:45 Roman Rouzier Course wrap-up
Cours Pasteur. Molecular Cancer Genetics. September 18-29, 2017
Cours Pasteur Molecular Cancer Genetics September 18-29, 2017 Directors François CLEMENT-BIDARD Co-director, Institut Curie Hospital Jean-Pierre VARTANIAN Co-director, Institut Pasteur PROGRAM 2017-2018
8 th course on NON-CODING GENOME February 13-20, 2019 Institut Curie - Training Unit - International Course
Wednesday, February 13 Non-coding genome and pervasive transcription Chairs: Antonin Morillon Sven Diederichs 11.30 12.30 Registration & LUNCH (sandwiches) 12.30 13.00 13.00 14.00 14.00 15.00 Antonin MORILLON
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER Seminar-Hotel Rigi am See Weggis Switzerland
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER 2016 Seminar-Hotel Rigi am See Weggis Switzerland Scientific Programme Each speaker in the programme will be careful to allow enough
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
Cours Pasteur. Molecular Cancer Genetics. September 24 October 5, Directors Jean-Pierre VARTANIAN Institut Pasteur. Sarah WATSON Institut Curie
Cours Pasteur Molecular Cancer Genetics September 24 October 5, 2018 Directors Jean-Pierre VARTANIAN Institut Pasteur Sarah WATSON Institut Curie PROGRAM 2018-2019 Molecular Cancer Genetics Room 4 & Laboratory
1 st course Genome Instability & Human Disease - May
1 st course Genome Instability & Human Disease - May 9-13 2016 A Training Unit International Course - Open conferences (in blue) Monday, May 9 th 09:45 Training Unit Institut Curie Sarah Lambert & Aura
PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
Thursday, May 4 Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Molecular Tumor Board - Case Presentation Lillian L. Siu, Patricio
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute
Saturday, August 20 25 th ANNUAL SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER August 20-28, 2016 Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins,
Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE
International Symposium th on Minimal Residual Cancer > Preliminary Program May 3-5, 2018 Le Corum MONTPELLIER, FRANCE Organizers: www.ismrc2018.com > Committee & Speakers > Welcome to Montpellier Scientific
27-28 November, 2017 Paris, France Espace Saint-Martin
27-28 November, 2017 Paris, France Espace Saint-Martin 199 bis rue Saint-Martin, 75003 Paris Immuno-oncology research and the subsequent development of immunotherapies continue to progress rapidly. We
Berlin. Title: Industry Satellite Symposium. Vienna. Title: Industry Satellite Symposium. Exhibition area. Title: Welcome reception
02.05.2019 12:00-13:00 Type: Industry Satellite Symposium 12:00-13:00 Type: Industry Satellite Symposium 13:00-13:30 Type: Opening session Title: Welcome reception Exhibition area 13:30-13:45 Type: Opening
French Networks for Sarcoma and GIST. O Mir, JY Blay
French Networks for Sarcoma and GIST O Mir, JY Blay Introduction Since 2009 a network of 26 reference multidisciplinary centers aiming to improve the quality of care for sarcoma patients in France was
Pasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY
Pasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY PROGRAM 2017-2018 INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY JUNE 25 th JUNE 29 th, 2018 Course directors Aroldo
Day 0 Sunday, July 8: Arrivals. Day 1 Monday, July 9: Introduction, Fundamentals, and Germline Variation. *As of 6/29/18
AACR Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine July 9-13, 2018 (*arrival July 8) Westin Copley Place, Boston Boston, Massachusetts *As of 6/29/18 Director:
Monday, 5 February 2018
Educational sessions for Junior audience Monday, 5 February 2018 09:30-11:00 Session 1 The diseases Chairs: Paolo. G Casali, IT; Paula Collini, IT 25 The natural history of STS & GIST Paolo. G Casali,
Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy Program Committee Martin Schuler, Essen (Chair) Cathrin Brisken,
Day 1: ESMO Sarcoma & GIST Faculty closed meeting
Day 1: ESMO Sarcoma & GIST Faculty closed meeting Sunday, 4 February 2018 12:30 14:00 Lunch 14:00-16:00 Discussion: Should we routinely use NGS? 120 Panel discussion 16:00 16:30 Coffee Break 16:30-18:00
2018: HORIZONS OF CANCER BIOLOGY AND THERAPY
2018: HORIZONS OF CANCER BIOLOGY AND THERAPY Day 1: Saturday September 08, 2018 Session 1: Opening Session 17:00-17:30 Charles Sawyers - New York, USA Drug Resistance in Cancer 17:30-18:00 Lisa Coussens
Clinical utility of precision medicine in oncology
Clinical utility of precision medicine in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900
Treating today s patients with tomorrow s solutions
Treating today s patients with tomorrow s solutions 1st conference supported by: European Multidisciplinary Breast Cancer Collaborative (EMBCC) February 5-6, 2016 Maison des oceans Paris EMBCC board members
Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications
An AACR Special Conference on October 12-15, 2011 The Fairmont San Francisco San Francisco, CA Wednesday, October 12 7:00 p.m.-8:00 p.m. Opening Keynote Address Chairperson: Jeffrey M. Rosen, Baylor College
International Conference of Cancer & Aging
International Conference of Cancer & Aging 23, 24, 25, & 26 October 2018 Wuhan, China Organized in collaboration with Institut Curie, Centre Léon Bérard, SFSO, HUST, BioLake, Université d Evry, PopsiCube,
1 st Montreal Symposium on Immunogenetics of Infectious and Inflammatory diseases
Monday, November 28 8:30 AM to 9:00 AM Arrival & Registration for all members 1 st Montreal Symposium on Immunogenetics of Monday and Tuesday November 28-29, 2016 New Residence Hall Ballroom 3625, Avenue
SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II
THURSDAY, SEPTEMBER 27 1200-1800 REGISTRATION Ballroom Foyer 1330-1430 WELCOME AND OPENING KEYNOTE LECTURE 1330-1340 Welcome from Scientific Committee Cochairs Carlos L. Arteaga, UT Southwestern Simmons
CRC 992 Symposium on Medical Epigenetics 2018
CRC 992 Symposium on Medical Epigenetics 2018 Monday, March 12 th Wednesday, March 14 th Agenda Lecture Hall Otto-Krayer-Haus Albertstr. 25 79104 Freiburg, Germany Day 1 Monday, March 12 th 2018, 14:30-19:30
Pasteur course MODELING OF INFECTIOUS DISEASES
Pasteur course MODELING OF INFECTIOUS DISEASES PROGRAM 2017-2018 Modeling of Infectious Diseases 2017-2018 CO-DIRECTORS OF THE COURSE Pierre -Yves BOËLLE Université Pierre et Marie Curie Hôpital Saint
PROGRAM RNA The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014
PROGRAM RNA 2014 The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014 (See room locations floor plan at the back of the book.) Tuesday June 3 14:00 20:00 Registration Foyer
ADVANCES IN SKELETAL MUSCLE BIOLOGY IN HEALTH AND DISEASE CONFERENCE PROGRAM
ADVANCES IN SKELETAL MUSCLE BIOLOGY IN HEALTH AND DISEASE CONFERENCE PROGRAM WEDNESDAY, March 6, 2019 Reitz Union, University of Florida 12:15-1:15pm Grant-Writing Workshop, Ground Floor Room G330 12:15-12:45
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases 10-11 October 2016 BORDEAUX (FR) 4 th ESSO Advanced Course on the Management of Colorectal Liver Metastases Chairs Serge Evrard,
SHIVA trial Prof. Christophe Le Tourneau Days of personalized medicine Vienne February 24, 2017
SHIVA trial Prof. Christophe Le Tourneau Institut Curie Paris & Saint-Cloud France Department of Medical Oncology Head of Early Phase Clinical Trials INSERM U900 Research unit Days of personalized medicine
SHIVA01 Prof. Christophe Le Tourneau, MD, PhD GFCO Paris October 11, 2017
SHIVA01 Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Department of Medical Oncology Head of Clinical Research INSERM U900 Research unit GFCO Paris October 11, 2017 Outline
3rd Human Cancer Immunology Course for Oncologists and Scientists A course for Clinicians and Investigators
Service de Médecine & Laboratoire d Investigation Clinique & d Oncologie Expérimentale : Pr Martine J. PICCART, Chef du Service de Médecine Centre des Tumeurs de l Université Libre de Bruxelles Tél. :
Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA
N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases 10-11 October 2016 BORDEAUX (FR) 4 th ESSO Advanced Course on the Management of Colorectal Liver Metastases Chairs Serge Evrard,
Christophe Mérieux Conference: New Trends in Tumor Virology
Sunday 17 January 2010 17.30-18.00 Registration 18.00 Welcome Address Guy VERNET - Fondation Mérieux Fabien ZOULIM - INSERM Opening Session 18.00-19.30 Chaired by Christian Bréchot & Massimo Tommasino
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines
EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study
EVATEL Study Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study Philippe Mabo, Pascal Defaye, Nicolas Sadoul, Jean Marc Davy, Jean-Claude Deharo, Salem Kacet, Eric
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Targeted Cancer Therapy April 26-29, 2012 Villa La Collina Cadenabbia (Co), Italy Program Committee Cathrin Brisken, Lausanne (Chair)
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening
8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY
CONFERENCE PROGRAM SATURDAY, OCTOBER 7 3:00 p.m.-7:00 p.m. Salon 3 of the Terrace Welcome and Keynote Lectures 6:00 p.m.-7:30 p.m. Session Chair: Ramon E. Parsons, Icahn School of Medicine at Mount Sinai,
EASL HCC SUMMIT 2018 FROM BASIC TO CLINICAL RESEARCH: HOW TO IMPROVE HCC CLINICAL CARE? 01 03, MARCH 2018 GENEVA, SWITZERLAND
EASL HCC SUMMIT 2018 FROM BASIC TO CLINICAL RESEARCH: HOW TO IMPROVE HCC CLINICAL CARE? 01 03, MARCH 2018 GENEVA, SWITZERLAND SCIENTIFIC ORGANISING COMMITTEE Alejandro Forner, Spain Peter Galle, Germany
Infos:
SPRING MEETING SWISS SOCIETY OF PHARMACOLOGY & TOXICOLOGY Pharmacology and Toxicology of Ageing: Integrating education from basic research to clinical science April 19, 2012 Inselspital Bern Infos: http://www.swisspharmtox.ch
Day One (Opening Day), Friday 22 Feb 2019 Concorde Hotel Time Session Speakers 8.45 AM 9.15 AM Registration
Day One (Opening Day), Friday 22 Feb 2019 Concorde Hotel 8.45 AM 9.15 AM Registration 9.15 AM 9.25 AM (10 min) Welcome Address Professor Lucy Reed 9.25 AM 10.00 AM (40 min) Introduction to the Dispute
Amreen Husain, 10 Eric P. Winer, 11 Sylvia Adams, 12 Peter Schmid 13
IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, Phase III study of atezolizumab + nab-paclitaxel in patients with treatment-naive, locally
Breast Cancer Statistics
1 in 8 Breast Cancer Statistics Incidence Mortality Prevalence 2 Breast Cancer Incidence Breast Cancer Mortality Breast Cancer Prevalence ~$100,000 Female Breast Anatomy Breasts consist mainly of fatty
Registration Continental Breakfast. Histone Modifications and Cancer- Part 1
Miami Epigenetics & Cancer Symposium Sunday, November 27 Tuesday, November 29, 2016 Ritz-Carlton, Miami Beach Conference Room: Collins for the Office SPEAKERS PROGRAM Sunday, November 27, 2016 Speakers
Course in Cancer Metabolism
Course in Cancer Metabolism November 29-30, 2018 CEUB - Bertinoro di Romagna (Italy) Course Directors Anna Maria Porcelli (University of Bologna, Italy) Giuseppe Gasparre (University of Bologna, Italy)
Molecularly Targeted Therapies: Mechanisms of Resistance
An AACR Special Conference on Molecularly Targeted Therapies: Mechanisms of Resistance May 9-12, 2012 Westin San Diego San Diego, CA Wednesday, May 9 7:00 p.m.-8:00 p.m. Opening Keynote Session BRAF and
Subject: The 9 th Meeting of the Joint CEOS/CGMS Working Group on Climate. Dear Colleagues,
Our ref.: EUM/OPS/LET/18/975872 Subject: The 9 th Meeting of the Joint CEOS/CGMS Working Group on Climate Dear Colleagues, I am pleased to invite you to the 9 th Meeting of the Joint CEOS/CGMS Working
4 th ONE-HEALTH COURSE. (Preliminary program)
4 th ONE-HEALTH COURSE (Preliminary program) 4-20 April 2016 Monday 4 April 2016 9h00-10h30 WEEK 1 WELCOME TO THE COURSE : PRESENTATION OF PROFESSORS AND STUDENTS Myriam ERMONVAL, Marc SAVEY & Noël TORDO
Welcome Remarks and Session Chair: Anil Rustgi, University of Pennsylvania, Philadelphia, PA
THURSDAY, SEPTEMBER 27 6:00 p.m. 7:00 p.m. OPENING KEYNOTE SESSION Welcome Remarks and Session Chair: Anil Rustgi, University of Pennsylvania, Philadelphia, PA Lgr5 stem cell-based organoids in cancer
Bivalent-chromatin and epigenetics alterations in Glioma
Bivalent-chromatin and epigenetics alterations in Glioma Philippe ARNAUD GReD CNRS 6293 - Clermont Universités- INSERM U1103 Clermont-Ferrand, FRANCE Forum de la Recherche en Cancérologie Auvergne-Rhône
From stem cells to human development
Exhibition and sponsorship opportunities Flexible opportunities and packages available to suit your marketing needs From stem cells to human development 23-26 September 2018 Wotton House, Surrey, UK This
Department of Research Evaluation. Université François-Rabelais de Tours Institut National de la Santé et de la Recherche Médicale - INSERM
Department of Research Evaluation report on research unit: Nutrition, Croissance et Cancer N2C under the supervision of the following institutions and research bodies: Université François-Rabelais de Tours
Venue: Spanish National Cancer Research Centre CNIO Auditorium, Madrid, Spain. Chairpersons and organizing committee:
Venue: Spanish National Cancer Research Centre CNIO Auditorium, Chairpersons and organizing committee: Victoria Aranda, Senior Editor, Nature, New York, US Nabil Djouder, Growth Factors, Nutrients and
FEBS ADVANCED LECTURE COURSE
FEBS ADVANCED LECTURE COURSE SUNDAY, August 25 From 16.00 Registration 19.15 - Opening remarks (organizers) 19.30 Self-presentation of all participants 21.00 Welcome reception MONDAY, August 26 Karen Knudsen,
SUPPLEMENTARY INFORMATION. CXCR4 inhibitors could benefit to HER2 but not to Triple-Negative. breast cancer patients
SUPPLEMENTARY INFORMATION CXCR4 inhibitors could benefit to HER2 but not to Triple-Negative breast cancer patients Lefort S. 1,2, Thuleau A. 3, Kieffer Y. 1,2, Sirven P. 1,2, Bieche I. 4, Marangoni E.
Mohamed Bentires-Alj
San Antonio Breast Cancer Symposium, December 6-10, 2016 Mohamed Bentires-Alj Professor of experimental surgical oncology Department of Biomedicine University of Basel University Hospital Basel m.bentires-alj@unibas.ch
Interna'onal congress on Cancer cell death and resistance
! Interna'onal congress on Cancer cell death and resistance May 6 and 7, 2013 h"p://kcelldeath.sciencesconf.org Golf of Seilh Near to Toulouse (Midi-Pyrénées, 31, France) Introduction Content : ² Introduction
HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies
EASL HCC SUMMIT 2017 2-5 February 2017, Geneva, Switzerland Scientific Committee: Basic Programme: Tom Luedde, Germany Helen Reeves, United Kingdom Clinical Programme: Alejandro Forner, Spain Franco Trevisani,
TrainMALTA Summer School on Epigenomics
TrainMALTA Summer School on Epigenomics 23-27 th July 2018, University of Malta TrainMALTA Partners: University of Malta University of Cambridge Katholieke Universiteit Leuven This project has received
Jean-Yves Pierga Medical Oncology Department & Circulating Biomarkers Lab, SIRIC, Institut Curie, Paris France
Circulating Tumor Cells in brain metastatic patients Jean-Yves Pierga Medical Oncology Department & Circulating Biomarkers Lab, SIRIC, Institut Curie, Paris France CTC and ctdna detection Cabel ( ) Pierga,
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Circulating tumour DNA in breast cancer. Kathleen Burke, PhD Bioinformatics Postdoctoral Fellow Laboratory of Dr. Jorge Reis-Filho
Circulating tumour DNA in breast cancer Kathleen Burke, PhD Bioinformatics Postdoctoral Fellow Laboratory of Dr. Jorge Reis-Filho Conflicts of Interest I have no financial relationships to disclose I will
The Organizing Committee. And the Scientific Committee members of COST Action BM RD EUROPEAN IMPRINTING DISORDER SCHOOL
The Organizing Committee Agnès Linglart Thomas Eggermann Deborah Mackay David Monk Irène Netchine Andrea Riccio Karen Temple And the Scientific Committee members of COST Action BM1208 Thomas Eggermann
This meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
PRESENTATION OF THE EXPERT GROUP
Workshop Monitoring immune modulation by nutrition in the general population PRESENTATION OF THE EXPERT GROUP Prof. Dr. Ulrich Sack Chair of the Expert Group 1 Expert Group Experts Prof. Ulrich Sack -
Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
ITCC-P4 International Workshop
ITCC P4 GA No. 116064 ITCC-P4 International Workshop IMPROVING PEDIATRIC ONCOLOGY DRUG DEVELOPMENT THROUGH PRECLINICAL RESEARCH September 27 th and 28 th, 2018 // Amsterdam, NL By invitation The event
Bayer to Present New Data on Advancing Oncology Portfolio. New Preclinical and Early Clinical Data Evaluating Innovative Compounds in Drug Development
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com 105 th Annual Meeting American Association for Cancer Research Bayer to Present
Strasbourg, 4-7 July Scientific Programme
The 10 th European Cytogenetics Conference Strasbourg, 4-7 July 2015 Scientific Programme SATURDAY, 4 JULY 2015 14:00-17:00 Permanent Working Group Meetings 17:00-17:50 Satellite Symposium 18:00-19:00
International workshop NO-CANCER 2017 From Cancerogenesis to Therapy: new paradigms, new opportunities
International workshop NO-CANCER 2017 From Cancerogenesis to Therapy: new paradigms, new opportunities ABOUT THE CONFERENCE SCIENTIFIC PROGRAM SOCIAL-CULTURAL PROGRAM SCIENTIFIC COMMITTEE AND ORGANIZING
(*Next Generation Sequencing)
(*Next Generation Sequencing) Patricia Aguilar Martinez, MD, PhD CHU de Montpellier, FRANCE & ENERCA WP leader 6 th European Symposium on Rare Anaemias-1 st Dutch-Belgian meeting for patients and health
Speakers. Text to be added
Speakers SESSION 1 Clinical status and perspectives for hereditary breast and ovarian cancer (HBOC) risk prediction. Fergus Couch Mayo Clinic Cancer Center and the Center for Individualized Medicine, Diana
Preventing BRCA-related cancer: A think tank for innovative strategies, milestone objectives and research priorities
BANBURY CENTER REPORTS Preventing BRCA-related cancer: A think tank for innovative strategies, milestone objectives and research priorities Banbury Center, Cold Spring Harbor Laboratory, Cold Spring Harbor,
Sunday 2 Monday 3 Tuesday 4 Wednesday 5. Presentation from Merck, followed by Lunch End of conference
Sunday 2 Monday 3 Tuesday 4 Wednesday 5 0845 Lectures in auditorium Keynote lecture: Miriam Keynote lecture: Coffee breaks in foyer C Poirier, Bethesda, Robert Turesky, USA Minnesota, USA 0900 Meals in
Time slots Sessions Location December 5 th (Friday) Friday Scientific Workshop on Myeloid Development
Overview of CML related sessions at the 56 th ASH Annual Meeting in San Francisco (USA) December 5-9, 2014 Time slots Sessions Location December 5 th (Friday) 13.00-19.15 Friday Scientific Workshop on
CNIO- la Caixa Foundation Frontiers Meeting- 2nd-4th MAY 2017 MOLECULAR CHAPERONES IN CANCER
Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain Chairpersons and organizing committee: Nabil Djouder, Spanish National Cancer Research Centre, Madrid, Spain Wilhelm Krek, Institute
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY A Joint Initiative of IAEA BELNUC - JULES BORDET INSTITUTE OCTOBER 2-6, 2017 Venue: Auditorium Tagnon Jules Bordet Institute Boulevard de
Jules Bordet Institute, Brussels, Belgium Université Libre de Bruxelles Breast International Group (BIG aisbl), Chair ESMO President
Symposium «Evaluation of the Belgian Cancer Plan» Brussels, November 26th, 2012 Personalized oncology in Europe: only a dream if national health systems do not get involved in diagnostics and pivotal cancer
Masterclass in: Iron principles and iron disorders
Masterclass in: Iron principles and iron disorders 8. February 2018 http://www.ironclub2018.ethz.ch/ ETH Zürich Iron Club Meeting 2018 Audimax HG F30 Rämistrasse 101 8092 Zürich Phone: +41 44 632 84 36
Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
SAVE THE DATE FOR THE 2019 AIRR COMMUNITY MEETING. Bridging the Gaps MAY 2019, Genoa, Italy
SAVE THE DATE FOR THE 2019 AIRR COMMUNITY MEETING Bridging the Gaps 11-15 MAY 2019, Genoa, Italy Dear AIRR Community Members and other Members of The An body Society, We are pleased to announce the 4th
Thursday, March 16 th
Thursday, March 16 th 08:45 Welcome Address Isabel Tavares de Almeida, SPDM President 9:00-11:00 Session I The future of diagnostics for IEM Chairpersons: Ronald Wanders, Amsterdam, NL and Sérgio B. de
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018
Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018 Wellcome Genome Campus, Hinxton, Cambridge, UK Conference Programme Wednesday 5 December 2018 12:00-13:00 Registration
ADVANCED IMMUNOLOGY COURSE
ADVANCED IMMUNOLOGY COURSE 2017-2018 MASTERS (M2) OF UNIVERSITIES PARIS DESCARTES, PIERRE ET MARIE CURIE ET DIDEROT PROGRAM FROM NOVEMBER 13TH 2017 TO JANUARY 9TH 2018 ADVANCED IMMUNOLOGY COURSE 2017-2018
31 st Annual Meeting Chicago 2018 Preliminary Program
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 15:00-18:00 SLTBR Board Meeting 31 st Annual Meeting Chicago 2018 Preliminary Program Wednesday, June 19 th 8:30-9:00 Registration Thursday,
1. Introduction. Correspondence should be addressed to François-Clément Bidard; Received 28 March 2013; Accepted 19 April 2013
International Breast Cancer Volume 203, Article ID 30470, 5 pages http://dx.doi.org/0.55/203/30470 Clinical Study Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy Program Committee Ursula Klingmüller, Heidelberg (Chair)
8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)
Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized
INNATE IMMUNITY and INFECTIOUS DISEASES
INNATE IMMUNITY and INFECTIOUS DISEASES April 10-25, 2017 PRELIMINARY INNATE IMMUNITY AND INFECTIOUS DISEASES COURSE (from April 10 to April 25, 2017) This two and half week long course offers lectures
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended
Metastatic breast cancer stem cells
Metastatic breast cancer stem cells Christophe GINESTIER, PhD Centre de Recherche en Cancérologie de Marseille Laboratoire d Oncologie Moléculaire Breast Stem Cell Group U168/Inserm/Institut Paoli-Calmettes
Course Schedule - Microanatomy
2006-2007 Course Schedule - Microanatomy Week 1: Basic Cell Biology Hour Monday 8-28 Tuesday 8-29 Wednesday 8-30 Thursday 8-31 Friday 9-1 Cell cytoplasm Structure and Function: Cell nucleus of Disease:
5 th Annual GABRIEL meeting 9-12 December, 2012 Les Pensières, Annecy, France
5 th Annual GABRIEL meeting 9-12 December, 2012 Les Pensières, Annecy, Organized by Fondation Mérieux With the participation of the «Réseau Science et Technique, Afrique Caraïbes de soutien à la lutte
Revised draft agenda Biocides Working Group Meeting II
14 March 2014 WG-II-2014 Revised draft agenda Biocides Working Group Meeting II - 2014 24-28 March 2014 ECHA Conference Centre (Annankatu 18, Helsinki) Coffee break 11:00-11:30 Lunch break 13:00-14:00